Cambodia vs Nigeria: Access to anti-retroviral drugs, female
Cambodia
89.0%
in 2024
Nigeria
89.0%
in 2024
Cambodia rank
35th
Nigeria rank
35th
Access to anti-retroviral drugs, female over time
- Cambodia
- Nigeria
How they compare
Cambodia currently reports 89.0% against 89.0% in Nigeria, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Nigeria ahead.
Cambodia ranks 35th and Nigeria ranks 35th of 141 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.1% | 5.0% | 10.1% | Cambodia |
| 2010s | 66.8% | 43.4% | 23.4% | Cambodia |
| 2020s | 85.4% | 78.6% | 6.8% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cambodia or Nigeria?
- Cambodia, at 89.0% against 89.0% in Nigeria as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cambodia and Nigeria?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Nigeria?
- 25 years are reported by both, from 2000 to 2024.
- How do Cambodia and Nigeria rank globally for access to anti-retroviral drugs, female?
- Cambodia ranks 35th and Nigeria ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.